Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
AAC Clyde Space | MKC0 | Nov 21, 2024 | 3.75 | -3.85 |
AAC TECH | A2XN | Nov 21, 2024 | 3.78 | +1.61 |
Aadi Bioscience | 3350 | Nov 21, 2024 | 2.08 | +4.00 |
AAK | 6AA0 | Nov 21, 2024 | 23.86 | +1.19 |
Aalberts NV | AACA | Nov 21, 2024 | 33.84 | -0.65 |
Aallon Group | I74 | Nov 21, 2024 | 7.86 | -1.01 |
AAP Implantate AG | AAQ1 | Nov 21, 2024 | 1.94 | -6.73 |
AAR Corp. | ARZ | Nov 21, 2024 | 63.45 | +0.48 |
AB Akola Group | YG4 | Nov 21, 2024 | 1.14 | -0.44 |
AB Amber Grid | AMH | Nov 21, 2024 | 1.12 | +2.75 |
AB Dynamics plc | 6DY | Nov 21, 2024 | 23.60 | -0.84 |
AB Ignitis Grupe | IGV0 | Nov 21, 2024 | 18.62 | +0.11 |
AB S.A. | 8B6 | Nov 21, 2024 | 20.20 | -1.94 |
Ab Science | A8D | Nov 21, 2024 | 0.78 | -4.28 |
ABACUS GRP UTS | EZO1 | Nov 21, 2024 | 0.71 | +0.24 |
Abacus Mining & Exploration Corp. | DGV2 | Nov 21, 2024 | 0.01 | 0.00 |
ABB Ltd | ABJA | Nov 21, 2024 | 53.50 | +2.88 |
Abbott Laboratories | ABL | Nov 21, 2024 | 109.68 | -0.71 |
AbbVie Inc. | 4AB | Nov 21, 2024 | 164.12 | +3.78 |
ABC | EK7 | Nov 21, 2024 | 0.42 | +1.01 |
ABC Arbitrage | 9BA | Nov 21, 2024 | 4.74 | -0.32 |
ABC-Mart Inc. | 5B8 | Nov 21, 2024 | 18.10 | -0.55 |
AbCellera Biologics Inc. - | 8QQ | Nov 21, 2024 | 2.50 | -0.99 |
Abcourt Mines, Inc. | AML | Nov 21, 2024 | 0.03 | +13.33 |
ABEN MINERALS LTD | R26 | Nov 21, 2024 | 0.03 | -10.61 |
Abercrombie & Fitch Company | AFT | Nov 21, 2024 | 132.90 | +1.26 |
Aberdeen Asia-Pacific Income Fund Inc | 9J9 | Nov 21, 2024 | 2.40 | 0.00 |
Aberdeen Asia-Pacificome Fund | 9J90 | Nov 21, 2024 | 14.44 | 0.00 |
Aberdeen International Inc | A8H | Nov 21, 2024 | 0.03 | +23.26 |
Aberdeen Standard European Logistics Income Plc | 5JX | Nov 21, 2024 | 0.69 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.